It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Moderna

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Pfizer won the first round, but Moderna sees final victory ahead

World Oct 30, 2021

Pfizer won the first round, but Moderna sees final victory ahead

by Robert Langreth and Riley Griffin

Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company’s mRNA technology gives it an advantage.

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

World Oct 15, 2021

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.

Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30

National / Science & Health Oct 14, 2021

Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30

by Osamu Tsukimori

Even as concerns grow about higher rates of myocarditis among young men who got the Moderna shot, the risk of developing the heart condition is still much lower than after getting COVID-19.

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

World Oct 11, 2021

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

by Rebecca Robbins

Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.

Japan's Takeda says 'human error' caused contamination of Moderna vaccines

National Oct 1, 2021

Japan's Takeda says 'human error' caused contamination of Moderna vaccines

by Rocky Swift

Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.

China's vaccine diplomacy drive falters as recipients turn to western shots

Asia Pacific Sep 30, 2021

China's vaccine diplomacy drive falters as recipients turn to western shots

by Iain Marlow and Randy Thanthong-Knight

In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.

Pfizer shot’s protection against hospitalization wanes in study

World Sep 20, 2021

Pfizer shot’s protection against hospitalization wanes in study

After four months, Moderna’s vaccine was 92% effective against hospitalization, with Pfizer’s at 77% and Johnson & Johnson's at 68%.

Japan plans to roll out booster shots by the end of the year

National / Science & Health Sep 17, 2021

Japan plans to roll out booster shots by the end of the year

by Ryusei Takahashi

Japan could soon start giving COVID-19 vaccine booster shots to people who are at least eight months removed from their second doses.

Moderna says COVID-19 vaccine protection wanes, makes case for booster

World Sep 16, 2021

Moderna says COVID-19 vaccine protection wanes, makes case for booster

Moderna on Sept. 1 submitted its application to the U.S. Food and Drug Administration seeking authorization for a booster shot.

Contaminants found in Pfizer vaccine in cities near Tokyo and Osaka

National Sep 15, 2021

Contaminants found in Pfizer vaccine in cities near Tokyo and Osaka

All three cities did not use doses containing foreign matter but continued using doses that were not contaminated.

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

National Sep 14, 2021

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.

Vaccines versus COVID-19: The great immunity debate

Commentary / World Sep 8, 2021

Vaccines versus COVID-19: The great immunity debate

by Faye Flam

There’s emerging evidence that getting sick provides better protection than at least one brand of shot. But people still need to get the jab.

« 1 2 3 4 … 9 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times